secwatch / observer
8-K filed March 20, 2024, 7:59 PM ET CIK 0000704562
regulatory confidence high sentiment negative materiality 0.75

Avid Bioservices, Inc.: Nasdaq/NYSE listing notice — Avid Bioservices receives Nasdaq delisting notice for late 10-Q due to restatement

Avid Bioservices, Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Avid Bioservices, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
late filing
Rules
5250(c)(1)
Exact text from the filing
March 19, 2024, Avid Bioservices, Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it was not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of its failure to file its Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2024 (the “Form 10-Q”) in a timely manner. The Rule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (th
View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR
accession 0001683168-24-001561
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.